Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

The E3 ubiquitin ligase TRIP12 participates in cell cycle progression and chromosome stability.

Larrieu D, Brunet M, Vargas C, Hanoun N, Ligat L, Dagnon L, Lulka H, Pommier RM, Selves J, Jády BE, Bartholin L, Cordelier P, Dufresne M, Torrisani J.

Sci Rep. 2020 Jan 21;10(1):789. doi: 10.1038/s41598-020-57762-9.

2.

MIAmS: microsatellite instability detection on NGS amplicons data.

Escudié F, Van Goethem C, Grand D, Vendrell J, Vigier A, Brousset P, Evrard SM, Solassol J, Selves J.

Bioinformatics. 2019 Oct 24. pii: btz797. doi: 10.1093/bioinformatics/btz797. [Epub ahead of print]

PMID:
31647522
3.

Direct comparison of the specialised blood fibrosis tests FibroMeterV2G and Enhanced Liver Fibrosis score in patients with non-alcoholic fatty liver disease from tertiary care centres.

Guillaume M, Moal V, Delabaudiere C, Zuberbuhler F, Robic MA, Lannes A, Metivier S, Oberti F, Gourdy P, Fouchard-Hubert I, Selves J, Michalak S, Peron JM, Cales P, Bureau C, Boursier J.

Aliment Pharmacol Ther. 2019 Dec;50(11-12):1214-1222. doi: 10.1111/apt.15529. Epub 2019 Oct 15.

PMID:
31617224
4.

Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth.

Roumenina LT, Daugan MV, Noé R, Petitprez F, Vano YA, Sanchez-Salas R, Becht E, Meilleroux J, Clec'h BL, Giraldo NA, Merle NS, Sun CM, Verkarre V, Validire P, Selves J, Lacroix L, Delfour O, Vandenberghe I, Thuilliez C, Keddani S, Sakhi IB, Barret E, Ferré P, Corvaïa N, Passioukov A, Chetaille E, Botto M, de Reynies A, Oudard SM, Mejean A, Cathelineau X, Sautès-Fridman C, Fridman WH.

Cancer Immunol Res. 2019 Jul;7(7):1091-1105. doi: 10.1158/2326-6066.CIR-18-0891. Epub 2019 Jun 4.

5.

Alteration of splicing factors' expression during liver disease progression: impact on hepatocellular carcinoma outcome.

Wang H, Lekbaby B, Fares N, Augustin J, Attout T, Schnuriger A, Cassard AM, Panasyuk G, Perlemuter G, Bieche I, Vacher S, Selves J, Péron JM, Bancel B, Merle P, Kremsdorf D, Hall J, Chemin I, Soussan P.

Hepatol Int. 2019 Jul;13(4):454-467. doi: 10.1007/s12072-019-09950-7. Epub 2019 May 28.

PMID:
31140152
6.

Predictive factors of histological response of colorectal liver metastases after neoadjuvant chemotherapy.

Serayssol C, Maulat C, Breibach F, Mokrane FZ, Selves J, Guimbaud R, Otal P, Suc B, Berard E, Muscari F.

World J Gastrointest Oncol. 2019 Apr 15;11(4):295-309. doi: 10.4251/wjgo.v11.i4.295.

7.

National multicentric evaluation of quality of pathology reports for rectal cancer in France in 2016.

Boutanos C, Capdepont M, Svrcek M, Thélu F, Guedj N, Poizat F, Bibeau F, Turlin B, Rousseau A, Bardier A, Selves J, Desrousseaux M, Le Pessot F, Bonhomme B, Laverrière MH, Julié C, Eyremandi RP, Stanislas S, Bazille C, Daubech A, Lazure T, Bordier MS, Demoures A, Rullier A.

Virchows Arch. 2019 May;474(5):561-568. doi: 10.1007/s00428-019-02534-8. Epub 2019 Feb 6.

PMID:
30729335
8.

Naevoid acanthosis nigricans or RAVEN (rounded and velvety epidermal naevus) and mosaic FGFR3 and FGFR2 mutations.

Bessis D, Petit A, Battistella M, Bourrat E, Girard C, Pallure V, Marque M, Lacour JP, Vitetta A, Bieth É, Selves J, Solassol J, Vendrell J.

Br J Dermatol. 2019 Apr;180(4):955-957. doi: 10.1111/bjd.17581. Epub 2019 Jan 17. No abstract available.

PMID:
30580445
9.

Germline mutation p.N363K in POLE is associated with an increased risk of colorectal cancer and giant cell glioblastoma.

Vande Perre P, Siegfried A, Corsini C, Bonnet D, Toulas C, Hamzaoui N, Selves J, Chipoulet E, Hoffmann JS, Uro-Coste E, Guimbaud R.

Fam Cancer. 2019 Apr;18(2):173-178. doi: 10.1007/s10689-018-0102-6.

PMID:
30368636
10.

[Guidelines for the management of malignant colo-rectal polyps (pTis and pT1) treated by endoscopic resection].

Selves J, Terris B, Cazals-Hatem D, Fléjou JF.

Ann Pathol. 2018 Dec;38(6):331-337. doi: 10.1016/j.annpat.2018.04.007. Epub 2018 Jul 26. French.

PMID:
30056944
11.

[Carcinoma of unknown primary. Case no. 3].

Selves J.

Ann Pathol. 2018 Jun;38(3):174-178. doi: 10.1016/j.annpat.2018.04.012. Epub 2018 Jun 19. Review. French. No abstract available.

PMID:
29929743
12.

[Carcinoma of unknown primary. Case no. 4].

Selves J.

Ann Pathol. 2018 Jun;38(3):179-184. doi: 10.1016/j.annpat.2018.04.013. Epub 2018 Jun 19. Review. French. No abstract available.

PMID:
29929741
13.

[Carcinoma of unknown primary. Role of the pathologist in 2018: Introduction].

Selves J, Long-Mira E, Mathieu MC, Rochaix P, Ilié M.

Ann Pathol. 2018 Jun;38(3):164-197. doi: 10.1016/j.annpat.2018.04.008. Epub 2018 Jun 19. French. No abstract available.

PMID:
29929740
14.

Correction: Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma.

Lièvre A, Ouine B, Canet J, Cartier A, Amar Y, Cacheux W, Mariani O, Guimbaud R, Selves J, Lecomte T, Guyetant S, Bieche I, Berger F, de Koning L.

Br J Cancer. 2018 Aug;119(3):387. doi: 10.1038/s41416-018-0130-x.

15.

CCDC115-CDG: A new rare and misleading inherited cause of liver disease.

Girard M, Poujois A, Fabre M, Lacaille F, Debray D, Rio M, Fenaille F, Cholet S, Ruel C, Caussé E, Selves J, Bridoux-Henno L, Woimant F, Dupré T, Vuillaumier-Barrot S, Seta N, Alric L, de Lonlay P, Bruneel A.

Mol Genet Metab. 2018 Jul;124(3):228-235. doi: 10.1016/j.ymgme.2018.05.002. Epub 2018 May 9.

PMID:
29759592
16.

Hepatitis E virus infection mimicking acute graft rejection in a liver transplant recipient.

Allaire M, Bazille C, Selves J, Salamé E, Altieri M.

Clin Res Hepatol Gastroenterol. 2018 Sep;42(4):e68-e71. doi: 10.1016/j.clinre.2017.12.005. Epub 2018 Apr 10.

PMID:
29650438
17.

Influence of Progenitor-Derived Regeneration Markers on Hepatitis C Virus-Related Cirrhosis Outcome (ANRS CO12 CirVir Cohort).

Wendum D, Layese R, Ganne-Carrié N, Bourcier V, Merabtene F, Cagnot C, Sauce E, Barget N, Bedossa P, Terris B, Selves J, Bioulac-Sage P, Sturm N, Sattonnet C, Nahon P, Roudot-Thoraval F, Ziol M; ANRS CO12 CirVir Group.

Hepatology. 2018 Oct;68(4):1534-1548. doi: 10.1002/hep.29927.

18.

Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site.

Selves J, Long-Mira E, Mathieu MC, Rochaix P, Ilié M.

Cancers (Basel). 2018 Apr 5;10(4). pii: E108. doi: 10.3390/cancers10040108. Review.

19.

Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK).

Michel P, Boige V, Andre T, Aparicio T, Bachet JB, Dahan L, Guimbaud R, Lepage C, Manfredi S, Tougeron D, Taieb J, Selves J, Le Malicot K, Di Fiore F, Maillard E.

Dig Liver Dis. 2018 Mar;50(3):305-307. doi: 10.1016/j.dld.2017.12.023. Epub 2017 Dec 30.

PMID:
29402752
20.

Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma.

Lièvre A, Ouine B, Canet J, Cartier A, Amar Y, Cacheux W, Mariani O, Guimbaud R, Selves J, Lecomte T, Guyetant S, Bieche I, Berger F, de Koning L.

Br J Cancer. 2017 Dec 5;117(12):1819-1827. doi: 10.1038/bjc.2017.353. Epub 2017 Oct 12. Erratum in: Br J Cancer. 2018 Aug;119(3):387.

21.

The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors.

Marisa L, Svrcek M, Collura A, Becht E, Cervera P, Wanherdrick K, Buhard O, Goloudina A, Jonchère V, Selves J, Milano G, Guenot D, Cohen R, Colas C, Laurent-Puig P, Olschwang S, Lefèvre JH, Parc Y, Boige V, Lepage C, André T, Fléjou JF, Dérangère V, Ghiringhelli F, de Reynies A, Duval A.

J Natl Cancer Inst. 2018 Jan 1;110(1). doi: 10.1093/jnci/djx136.

PMID:
28922790
22.

Detection of viral hepatitis E in clinical liver biopsies.

Prost S, Crossan CL, Dalton HR, De Man RA, Kamar N, Selves J, Dhaliwal C, Scobie L, Bellamy COC.

Histopathology. 2017 Oct;71(4):580-590. doi: 10.1111/his.13266. Epub 2017 Aug 7.

PMID:
28543644
23.

High-throughput detection of clinically targetable alterations using next-generation sequencing.

Vendrell JA, Grand D, Rouquette I, Costes V, Icher S, Selves J, Larrieux M, Barbe A, Brousset P, Solassol J.

Oncotarget. 2017 Jun 20;8(25):40345-40358. doi: 10.18632/oncotarget.15875.

24.

Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies.

Del Rio M, Mollevi C, Bibeau F, Vie N, Selves J, Emile JF, Roger P, Gongora C, Robert J, Tubiana-Mathieu N, Ychou M, Martineau P.

Eur J Cancer. 2017 May;76:68-75. doi: 10.1016/j.ejca.2017.02.003. Epub 2017 Mar 8.

PMID:
28284171
25.

Primary giant cell tumor of the common bile duct: No mutation H3F3A found.

Beaufrère A, Larousserie F, Dokmak S, Pasmant E, Selves J, Cazals-Hatem D.

Pathol Int. 2017 Apr;67(4):225-227. doi: 10.1111/pin.12510. Epub 2017 Jan 20. No abstract available.

PMID:
28105671
26.

Endoscopic ultrasound-guided fine-needle aspiration plus KRAS and GNAS mutation in malignant intraductal papillary mucinous neoplasm of the pancreas.

Bournet B, Vignolle-Vidoni A, Grand D, Roques C, Breibach F, Cros J, Muscari F, Carrère N, Selves J, Cordelier P, Buscail L.

Endosc Int Open. 2016 Dec;4(12):E1228-E1235. Epub 2016 Nov 10.

27.

Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.

Nault JC, Couchy G, Balabaud C, Morcrette G, Caruso S, Blanc JF, Bacq Y, Calderaro J, Paradis V, Ramos J, Scoazec JY, Gnemmi V, Sturm N, Guettier C, Fabre M, Savier E, Chiche L, Labrune P, Selves J, Wendum D, Pilati C, Laurent A, De Muret A, Le Bail B, Rebouissou S, Imbeaud S; GENTHEP Investigators, Bioulac-Sage P, Letouzé E, Zucman-Rossi J.

Gastroenterology. 2017 Mar;152(4):880-894.e6. doi: 10.1053/j.gastro.2016.11.042. Epub 2016 Dec 7.

28.

Erratum to: Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression.

Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, Selves J, Laurent-Puig P, Sautès-Fridman C, Fridman WH, de Reyniès A.

Genome Biol. 2016 Dec 1;17(1):249. No abstract available.

29.

Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression.

Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, Selves J, Laurent-Puig P, Sautès-Fridman C, Fridman WH, de Reyniès A.

Genome Biol. 2016 Oct 20;17(1):218. Erratum in: Genome Biol. 2016 Dec 1;17 (1):249.

30.

Clinical characteristics and outcome of cirrhotic patients with high protein concentrations in ascites: a prospective study.

Guillaume M, Robic MA, Péron JM, Selves J, Otal P, Sirach E, Vinel JP, Bureau C.

Eur J Gastroenterol Hepatol. 2016 Nov;28(11):1268-74. doi: 10.1097/MEG.0000000000000697.

PMID:
27380602
31.

Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts.

Moatassim-Billah S, Duluc C, Samain R, Jean C, Perraud A, Decaup E, Cassant-Sourdy S, Bakri Y, Selves J, Schmid H, Martineau Y, Mathonnet M, Pyronnet S, Bousquet C.

Oncotarget. 2016 Jul 5;7(27):41584-41598. doi: 10.18632/oncotarget.9296.

32.

KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma.

Bournet B, Muscari F, Buscail C, Assenat E, Barthet M, Hammel P, Selves J, Guimbaud R, Cordelier P, Buscail L.

Clin Transl Gastroenterol. 2016 Mar 24;7:e157. doi: 10.1038/ctg.2016.18.

33.

Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy.

Becht E, de Reyniès A, Giraldo NA, Pilati C, Buttard B, Lacroix L, Selves J, Sautès-Fridman C, Laurent-Puig P, Fridman WH.

Clin Cancer Res. 2016 Aug 15;22(16):4057-66. doi: 10.1158/1078-0432.CCR-15-2879. Epub 2016 Mar 18.

34.

HSP110 T17 simplifies and improves the microsatellite instability testing in patients with colorectal cancer.

Buhard O, Lagrange A, Guilloux A, Colas C, Chouchène M, Wanherdrick K, Coulet F, Guillerm E, Dorard C, Marisa L, Bokhari A, Greene M, El-Murr N, Bodo S, Muleris M, Sourouille I, Svrcek M, Cervera P, Blanché H, Lefevre JH, Parc Y, Lepage C, Chapusot C, Bouvier AM, Gaub MP, Selves J, Garrett K, Iacopetta B, Soong R, Hamelin R, Garrido C, Lascols O, André T, Fléjou JF, Collura A, Duval A.

J Med Genet. 2016 Jun;53(6):377-84. doi: 10.1136/jmedgenet-2015-103518. Epub 2016 Feb 1.

PMID:
26831756
35.

[Specific morphology of a rare ovarian tumor].

Siegfried A, Selves J, Delsol M, Duga I, Danjoux M, Aziza J.

Ann Pathol. 2015 Dec;35(6):540-2. doi: 10.1016/j.annpat.2015.05.018. Epub 2015 Nov 14. French. No abstract available.

PMID:
26586012
36.

Chromosomal rearrangements involving the NTRK1 gene in colorectal carcinoma.

Créancier L, Vandenberghe I, Gomes B, Dejean C, Blanchet JC, Meilleroux J, Guimbaud R, Selves J, Kruczynski A.

Cancer Lett. 2015 Aug 28;365(1):107-11. doi: 10.1016/j.canlet.2015.05.013. Epub 2015 May 19.

PMID:
26001971
37.

Outcomes of nonresected main-duct intraductal papillary mucinous neoplasms of the pancreas.

Daudé M, Muscari F, Buscail C, Carrère N, Otal P, Selves J, Buscail L, Bournet B.

World J Gastroenterol. 2015 Mar 7;21(9):2658-67. doi: 10.3748/wjg.v21.i9.2658.

38.

Serum tests, liver stiffness and artificial neural networks for diagnosing cirrhosis and portal hypertension.

Procopet B, Cristea VM, Robic MA, Grigorescu M, Agachi PS, Metivier S, Peron JM, Selves J, Stefanescu H, Berzigotti A, Vinel JP, Bureau C.

Dig Liver Dis. 2015 May;47(5):411-6. doi: 10.1016/j.dld.2015.02.001. Epub 2015 Feb 7.

PMID:
25732434
39.

PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer.

Manceau G, Marisa L, Boige V, Duval A, Gaub MP, Milano G, Selves J, Olschwang S, Jooste V, le Legrain M, Lecorre D, Guenot D, Etienne-Grimaldi MC, Kirzin S, Martin L, Lepage C, Bouvier AM, Laurent-Puig P.

Cancer Med. 2015 Mar;4(3):371-82. doi: 10.1002/cam4.370. Epub 2015 Feb 2.

40.
41.

Targeted oncolytic herpes simplex virus type 1 eradicates experimental pancreatic tumors.

Gayral M, Lulka H, Hanoun N, Biollay C, Sèlves J, Vignolle-Vidoni A, Berthommé H, Trempat P, Epstein AL, Buscail L, Béjot JL, Cordelier P.

Hum Gene Ther. 2015 Feb;26(2):104-13. doi: 10.1089/hum.2014.072. Epub 2015 Jan 19.

42.

MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer.

Gayral M, Jo S, Hanoun N, Vignolle-Vidoni A, Lulka H, Delpu Y, Meulle A, Dufresne M, Humeau M, Chalret du Rieu M, Bournet B, Sèlves J, Guimbaud R, Carrère N, Buscail L, Torrisani J, Cordelier P.

World J Gastroenterol. 2014 Aug 28;20(32):11199-209. doi: 10.3748/wjg.v20.i32.11199. Review.

43.

Role of endoscopic ultrasound in the molecular diagnosis of pancreatic cancer.

Bournet B, Gayral M, Torrisani J, Selves J, Cordelier P, Buscail L.

World J Gastroenterol. 2014 Aug 21;20(31):10758-68. doi: 10.3748/wjg.v20.i31.10758. Review.

44.

Sporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study.

Kirzin S, Marisa L, Guimbaud R, De Reynies A, Legrain M, Laurent-Puig P, Cordelier P, Pradère B, Bonnet D, Meggetto F, Portier G, Brousset P, Selves J.

PLoS One. 2014 Aug 1;9(8):e103159. doi: 10.1371/journal.pone.0103159. eCollection 2014.

45.

Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with a KRAS mutation assay using allelic discrimination improves the diagnosis of pancreatic cancer.

Bournet B, Selves J, Grand D, Danjoux M, Hanoun N, Cordelier P, Buscail L.

J Clin Gastroenterol. 2015 Jan;49(1):50-6. doi: 10.1097/MCG.0000000000000053.

PMID:
24798941
46.

Impact of chromosomal instability on colorectal cancer progression and outcome.

Orsetti B, Selves J, Bascoul-Mollevi C, Lasorsa L, Gordien K, Bibeau F, Massemin B, Paraf F, Soubeyran I, Hostein I, Dapremont V, Guimbaud R, Cazaux C, Longy M, Theillet C.

BMC Cancer. 2014 Feb 22;14:121. doi: 10.1186/1471-2407-14-121.

47.

Patients with colorectal tumors with microsatellite instability and large deletions in HSP110 T17 have improved response to 5-fluorouracil–based chemotherapy.

Collura A, Lagrange A, Svrcek M, Marisa L, Buhard O, Guilloux A, Wanherdrick K, Dorard C, Taieb A, Saget A, Loh M, Soong R, Zeps N, Platell C, Mews A, Iacopetta B, De Thonel A, Seigneuric R, Marcion G, Chapusot C, Lepage C, Bouvier AM, Gaub MP, Milano G, Selves J, Senet P, Delarue P, Arzouk H, Lacoste C, Coquelle A, Bengrine-Lefèvre L, Tournigand C, Lefèvre JH, Parc Y, Biard DS, Fléjou JF, Garrido C, Duval A.

Gastroenterology. 2014 Feb;146(2):401-11.e1.

PMID:
24512910
48.

Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma.

Poussin K, Pilati C, Couchy G, Calderaro J, Bioulac-Sage P, Bacq Y, Paradis V, Leteurtre E, Sturm N, Ramos J, Guettier C, Bardier-Dupas A, Boulai A, Wendum D, Selves J, Izard T, Nault JC, Zucman-Rossi J.

Oncoimmunology. 2013 Dec 1;2(12):e27090. Epub 2014 Jan 3.

49.

[Kras oncogene and pancreatic cancer: thirty years after].

Bournet B, Dufresne M, Selves J, Torrisani J, Cordelier P, Buscail L.

Med Sci (Paris). 2013 Nov;29(11):991-7. doi: 10.1051/medsci/20132911015. Epub 2013 Nov 20. Review. French.

50.

Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.

Marisa L, de Reyniès A, Duval A, Selves J, Gaub MP, Vescovo L, Etienne-Grimaldi MC, Schiappa R, Guenot D, Ayadi M, Kirzin S, Chazal M, Fléjou JF, Benchimol D, Berger A, Lagarde A, Pencreach E, Piard F, Elias D, Parc Y, Olschwang S, Milano G, Laurent-Puig P, Boige V.

PLoS Med. 2013;10(5):e1001453. doi: 10.1371/journal.pmed.1001453. Epub 2013 May 21.

Supplemental Content

Loading ...
Support Center